E. Nigma
Guest
|
 Posted: Wed Nov 19, 2008 8:25 am Post subject: This Week>s NCI Cancer Bulletin: November 18, 2008 |
 |
|
-----BEGIN PGP SIGNED MESSAGE-----
In this issue of the NCI Cancer Bulletin:
http://www.cancer.gov/ncicancerbulletin/NCI_Cancer_Bulletin_111808
Featured Article
NCI Technology Research Facility Gets Off the Ground
Cancer Research Highlights
Bevacizumab May Increase Blood Clot Risk
Number of Adult U.S. Smokers Drops, But So Do Quit Attempts
PAX2 Protein Mediates Effect of Tamoxifen in Breast Cancer
Burden of Cervical Cancer Prior to HPV Vaccine Assessed
Director>s Update
Building an Advanced Technology Research Initiative
FDA Update
New Option Approved for Indolent NHL
Special Report
A Cancer Genome is Sequenced, Revealing Rare Mutations
Featured Clinical Trial
New Drug for Patients with Advanced Thyroid Cancer
Special Issue on Cancer Imaging
Spotlight
Cancer Disparities: A Biological and Psychosocial Perspective
Also in the Journals
Community Update
Researchers Consider "NCI Translates" Approach
Notes
NCI Advisors Approve Major Cancer Research Initiatives
Understanding NCI Teleconference: Translational Research Working
Group
In Memoriam
Dr. Ronald M. Davis
Cancer Center Profile
Memorial Sloan-Kettering Cancer Center
============
Do you know someone who would enjoy receiving the NCI Cancer
Bulletin? To send a copy of the latest issue to a colleague, visit
www.cancer.gov/ncicancerbulletin. The NCI Cancer Bulletin will be
sent to you each week unless you ask to unsubscribe.
============
E.
-----BEGIN PGP SIGNATURE-----
Version: PGP Personal Privacy 6.5.3
iQEVAwUBSSN8WNAqdZr/mrO9AQFotwgAq3s2Uwlw8gHVehvJgmmkQfKCAIutnE/C
e88o6KHO05ETeGO9+gyzKgb7AKND54Lnbjw9lDhHxe4zJEiC2Iyv5AcLg0AExG6u
u40O+0Zp22kdBWgp50PsClfESrzR+Rp9uAdlAzuITyh75F3AD7+TwGZxKxfjKO7/
RmnDfXDKE0DJeU9lO11xhNcIkg1Vi2VTJ/jlUI9I2uDTv9+FCz8xJGHypb86BDYx
3/ZXafeIAGba0vVQkodKIbBHf9W5IE/sHyfimni1vZO2FsG+niackex0qOuHKOPk
9fzltPhRn8ee8KGocn10Bo0bu9+F0kaRP3lWE4bZ7BVJQ5m51uHoRg==
=rQ+U
-----END PGP SIGNATURE----- |
|
